https://specialty.mims.com/topic/first-line-sglt2-inhibitors--glp1-receptor-agonists-need-to-cut-price-to-be-cost-effective
First-line treatment with sodium–glucose cotransporter-2 (SGLT2) inhibitors or glucagon-like peptide-1 (GLP1) receptor agonists improves outcome...
Create an account or login to join the discussion